By Mark Melchionna March 06, 2023 – Amid a rapidly growing youth mental health crisis, Brightline and Evernorth Health Services have formed a partnership to support children and their families by expanding…
Continue Reading
Jayne Goes to ATA
I have arrived at the American Telemedicine Association meeting in San Antonio, escaping the freezing rain of the Midwest for the blindingly bright sun of Texas.
Since it’s been…
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading
TALi obtains Australia’s nod for cognitive attention trainer deviceTALi Digital, an ASX-listed developer of diagnostic and therapeutic tools for improving children’s attention, has received the Therapeutic Goods Administration’s approval for its latest product, ReadyAttentionGo!
Available…
The Australian Digital Health Agency has come up with its first mobile consumer application for accessing health information on My Health Record.WHAT IT DOES
Available on both iOS and Android devices, the my health app…
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment
R-Zero, a global leader in healthy buildings and green buildings, today announced it has…
What You Should Know:– Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery…
Continue Reading
SetPoint Medical, a medtech company based in California, is developing a neuromodulatory device that is intended to treat rheumatoid arthritis. The overlap between the nervous and immune systems is increasingly appreciated, and this technology…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies…
Continue Reading
